K. A. Papp, J. F. Merola, A. B. Gottlieb, and E. al., “Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response”, J of Skin, vol. 2, p. S92, Dec. 2018.